Teva Pharmaceutical Industries Ltd Adr (TEVA)

Finanzdaten der Teva Pharmaceutical Industries Ltd Adr-Aktie (TEVA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	4.02%4,142.00	3,982.00	1,500.00	4,480.00	4,176.00
Cost Of Revenue	1.09%1,989.00	2,011.00	2,056.00	2,176.00	2,074.00
Gross Profit	9.18%2,153.00	1,972.00	2,656.00	2,304.00	2,102.00
Depreciation and Amortization	0.84%241.00	239.00	260.00	249.00	251.00
Operating Income/Loss	135.43%-231.00	652.00	300.00	882.00	455.00
Nonoperating Income/Loss	3.70%-224.00	-216.00	-220.00	-237.00	-252.00
Income/Loss From Equity Method Investments	300.00%2.00	-1.00	11.00	2.00	1.00
Income/Loss From Continuing Operations Before Tax	204.12%-455.00	437.00	1,500.00	646.00	203.00
Income Tax Expense/Benefit	80.60%121.00	67.00	-390.00	214.00	-78.00
	255.83%-575.00	369.00	481.00	434.00	283.00
Attributable To Parent	256.10%-576.00	369.00	480.00	433.00	282.00
Basic Average Shares	0.78%1,165.00	1,156.00	1.00	1,147.00	1,147.00
Diluted Average Shares	1.19%1,165.00	1,179.00	3.00	1,164.00	1,161.00
Basic Earnings Per Share	253.13%-0.49	0.32	0.42	0.38	0.25
Diluted Earnings Per Share	258.06%-0.49	0.31	0.41	0.37	0.24